Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee P Richman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancer Immunology Research|January 14, 2014
Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancerLee P Richman, Robert H Vonderheide
Oncoimmunology|August 7, 2014
Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinkingLee P Richman, Robert H Vonderheide
Cell Systems|October 14, 2019
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint BlockadeLee P Richman, Robert H Vonderheide, Andrew J Rech
Cell Genomics|February 23, 2023
ClonoCluster: A method for using clonal origin to inform transcriptome clusteringLee P Richman, Yogesh Goyal, Connie L Jiang, et al.
European Journal of Immunology|February 3, 2015
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in miceSheena R Baratono, Niansheng Chu, Lee P Richman, et al.
American Journal of Clinical Pathology|May 25, 2025
Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation statusLee P Richman, Brianna F Waller, Scott B Lovitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease ProphylaxisAustin P Huffman, Lee P Richman, Lisa Crisalli, et al.
Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2026
Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath TumorLee P Richman, Phillip D Michaels, Corrine Nief, et al.
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer Immunology Research|January 14, 2014
Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancerLee P Richman, Robert H Vonderheide
Oncoimmunology|August 7, 2014
Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinkingLee P Richman, Robert H Vonderheide
Cell Systems|October 14, 2019
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint BlockadeLee P Richman, Robert H Vonderheide, Andrew J Rech
Cell Genomics|February 23, 2023
ClonoCluster: A method for using clonal origin to inform transcriptome clusteringLee P Richman, Yogesh Goyal, Connie L Jiang, et al.
European Journal of Immunology|February 3, 2015
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in miceSheena R Baratono, Niansheng Chu, Lee P Richman, et al.
American Journal of Clinical Pathology|May 25, 2025
Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation statusLee P Richman, Brianna F Waller, Scott B Lovitch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease ProphylaxisAustin P Huffman, Lee P Richman, Lisa Crisalli, et al.
Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2026
Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath TumorLee P Richman, Phillip D Michaels, Corrine Nief, et al.
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Pageof 3